Personal information

Emails & domains

Verified email domains

Websites & social links

LinkedIn

Keywords

Asthma, Immunology

Activities

Collapse all

Employment (2)

Ghent University Hospital: Ghent, BE

2022-10-01 to present | PhD-fellow (Pulmonology department)
Employment
Source: Self-asserted source
Sebastian Riemann

Ghent University: Ghent, BE

2022-10-01 to present | PhD-fellow (Faculty of Medicine and Health Sciences)
Employment
Source: Self-asserted source
Sebastian Riemann

Education and qualifications (1)

Ghent University: Ghent, BE

2019-09-23 to 2022-06-30 | Master of medicine in medicine (Faculty of medicine and health sciences)
Education
Source: Self-asserted source
Sebastian Riemann

Professional activities (2)

European Respiratory Society: Lausanne, CH

2022-10-07 to present | Clinical researcher
Membership
Source: Self-asserted source
Sebastian Riemann

Belgian Respiratory Society: Brussels, BE

2022-10-03 to present | Toetredend Junior lid
Membership
Source: Self-asserted source
Sebastian Riemann

Works (7)

Replication stress, microcephalic primordial dwarfism, and compromised immunity in ATRIP deficient patients

Journal of Experimental Medicine
2025-05-05 | Journal article
DOI: 10.1084/jem.20241432
Contributors: Evi Duthoo; Elien Beyls; Lynn Backers; Thorkell Gudjónsson; Peiquan Huang; Leander Jonckheere; Sebastian Riemann; Bram Parton; Likun Du; Veronique Debacker et al.
Source: check_circle
Crossref

Need for sex-stratified reference values for exhaled nitric oxide as biomarker in chronic cough

ERJ Open Research
2024-07 | Journal article
DOI: 10.1183/23120541.00202-2024
Contributors: Sebastian Riemann; Johnmary T. Arinze; Andrei Malinovschi; Guy G. Brusselle
Source: check_circle
Crossref

ATRIP deficiency impairs the replication stress response and manifests as microcephalic primordial dwarfism and immunodeficiency

2024-07-23 | Preprint
DOI: 10.1101/2024.07.22.24310550
Contributors: Evi Duthoo; Elien Beyls; Lynn Backers; Thorkell Gudjónsson; Peiquan Huang; Leander Jonckheere; Sebastian Riemann; Bram Parton; Likun Du; Veronique Debacker et al.
Source: check_circle
Crossref

Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration’s adverse event reporting system (FAERS)

Frontiers in Pharmacology
2023-11-14 | Journal article | Writing - original draft, Writing - review & editing
DOI: 10.3389/fphar.2023.1276340
Part of ISSN: 1663-9812
Contributors: Victor Pera; Guy G. Brusselle; Sebastian Riemann; Jan A. Kors; Erik M. Van Mulligen; Rowan Parry; Marcel de Wilde; Peter R. Rijnbeek; Katia M. C. Verhamme
Source: Self-asserted source
Sebastian Riemann

Reply to Lipworth and Chan

American Journal of Respiratory and Critical Care Medicine
2023-07-15 | Journal article
DOI: 10.1164/rccm.202305-0792LE
Contributors: Guy Brusselle; Sebastian Riemann
Source: check_circle
Crossref

Is Efficacy of Tezepelumab Independent of Severe Asthma Phenotype?

American Journal of Respiratory and Critical Care Medicine
2023-07-01 | Journal article
DOI: 10.1164/rccm.202304-0700ED
Contributors: Guy Brusselle; Sebastian Riemann
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Mepolizumab attenuates ILC2s proliferation and activity in adults with severe eosinophilic asthma

Respirology
2023-05-10 | Journal article
DOI: 10.1111/resp.14517
Part of ISSN: 1323-7799
Part of ISSN: 1440-1843
Contributors: Guy Brusselle; Sebastian Riemann; Tania Maes
Source: Self-asserted source
Sebastian Riemann
How many people are using ORCID?